Posted: March 7th, 2023

Think About A Familiar Clinical Practice Area

Think About A Familiar Clinical Practice Area Where Interest Groups Are Attempting To Bring About A Change In Clinical Care Or Systems Of Service DeliveryThink about a familiar clinical practice area where interest groups are attempting to bring about a change in clinical care or systems of service delivery. Assume new, game-changing research finding are published and received wide attention. Identify groups that might have an interest in these finding. What are their likely reactions to new research?

The discussion must address the topic.

Rationale must be provided

400 words in your initial post by Wednesday 23:59 pm

Minimum of two scholarly references in APA format within the last five years published

You must post two answers to your peers peers of 200 words by Thursday 23:59 pm.
One familiar clinical practice area where interest groups are attempting to bring about a change in clinical care is mental health. Mental health has long been a topic of interest and discussion, and in recent years, there have been numerous advancements in the field, including new research findings. One game-changing research finding that has recently received wide attention is the effectiveness of psychedelic-assisted therapy in the treatment of mental health disorders such as depression, anxiety, and PTSD.

The groups that might have an interest in these findings include mental health professionals, patients with mental health disorders, advocacy groups for mental health, regulatory bodies, and pharmaceutical companies. Mental health professionals such as therapists, psychiatrists, and counselors are likely to be interested in these findings because it could change the way they practice and offer new, innovative treatments to their patients. Patients with mental health disorders are likely to be interested in these findings because it could offer a new, effective treatment option that could significantly improve their quality of life.

Advocacy groups for mental health, such as the National Alliance on Mental Illness (NAMI), are also likely to be interested in these findings because it could potentially lead to changes in healthcare policy, insurance coverage, and access to care. Regulatory bodies, such as the Food and Drug Administration (FDA), are likely to be interested in these findings because it could lead to the approval and regulation of new treatments. Finally, pharmaceutical companies are likely to be interested in these findings because it could lead to the development of new drugs and therapies that could be profitable.

The likely reactions of these groups to new research are varied. Mental health professionals, patients, and advocacy groups are likely to be excited about the potential new treatment option and advocate for increased access to psychedelic-assisted therapy. Regulatory bodies are likely to carefully review the findings and ensure that the treatment is safe and effective before approving it for use. Pharmaceutical companies are likely to conduct their own research and potentially develop new drugs and therapies based on the findings.

In conclusion, the new research findings on psychedelic-assisted therapy have the potential to bring about significant changes in the field of mental health. The interest groups that have a stake in mental health are likely to have varied reactions to the findings, but ultimately, the hope is that it will lead to improved care and outcomes for patients with mental health disorders.

References:

Carhart-Harris, R. L., Bolstridge, M., Day, C. M. J., Rucker, J., Watts, R., Erritzoe, D. E., … & Nutt